Filing Details

Accession Number:
0000096943-19-000160
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-02 17:31:44
Reporting Period:
2019-10-01
Accepted Time:
2019-10-02 17:31:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
96943 Teleflex Inc TFX Surgical & Medical Instruments & Apparatus (3841) 231147939
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242740 E Thomas Powell 550 E Swedesford Road
Suite 400
Wayne PA 19087
Executive Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-01 7,500 $101.12 18,197 No 4 M Direct
Common Stock Disposition 2019-10-01 79 $333.57 18,118 No 4 S Direct
Common Stock Disposition 2019-10-01 627 $335.41 17,491 No 4 S Direct
Common Stock Disposition 2019-10-01 1,260 $336.35 16,231 No 4 S Direct
Common Stock Disposition 2019-10-01 1,534 $337.50 14,697 No 4 S Direct
Common Stock Disposition 2019-10-01 1,300 $338.73 13,397 No 4 S Direct
Common Stock Disposition 2019-10-01 2,700 $339.73 10,697 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option / (Right to Buy) Disposition 2019-10-01 7,500 $0.00 7,500 $101.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,842 2024-02-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 386 Indirect By 401(k) Trustee
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on August 6, 2019.
  2. This transaction was executed in multiple trades at prices ranging from $335.00 to $335.81. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $336.08 to $336.82. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $337.085 to $337.85. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $338.29 to $339.25. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $339.44 to $340.17. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. Exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017.